344
Views
28
CrossRef citations to date
0
Altmetric
Reviews

Rationalization and prediction of in vivo metabolite exposures: the role of metabolite kinetics, clearance predictions and in vitro parameters

, PharmD, , PhD & , MSc PhD
Pages 1095-1109 | Published online: 17 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Austin C. Li, Donghui Cui, Erya Yu, Kyle Dobson, Edward T. Hellriegel & Philmore Robertson Jr. (2019) Identification and human exposure prediction of two aldehyde oxidase-mediated metabolites of a methylquinoline-containing drug candidate. Xenobiotica 49:3, pages 302-312.
Read now

Articles from other publishers (26)

Byron Kuo, Marc A. Beal, John W. Wills, Paul A. White, Francesco Marchetti, Andy Nong, Tara S. Barton-Maclaren, Keith Houck & Carole L. Yauk. (2022) Comprehensive interpretation of in vitro micronucleus test results for 292 chemicals: from hazard identification to risk assessment application. Archives of Toxicology 96:7, pages 2067-2085.
Crossref
Samantha Faber, Tejas Lahoti, Ewan Taylor, Lauren Lewis, Jessica Sapiro, Vicencia Toledo Sales, Yvonne Dragan & Brandon Jeffy. (2022) Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications. Cells 11:10, pages 1708.
Crossref
Daigo Asano, Syoya Hamaue, Hamim Zahir, Hideyuki Shiozawa, Yumi Nishiya, Takako Kimura, Miho Kazui, Naotoshi Yamamura, Marie Ikeguchi, Takahiro Shibayama, Shin-ichi Inoue, Tsuyoshi Shinozuka, Toshiyuki Watanabe, Chizuko Yahara, Nobuaki Watanabe & Kouichi Yoshinari. (2022) CYP2C8-Mediated Formation of a Human Disproportionate Metabolite of the Selective Na V 1.7 Inhibitor DS-1971a, a Mixed Cytochrome P450 and Aldehyde Oxidase Substrate . Drug Metabolism and Disposition 50:3, pages 235-242.
Crossref
Kiho Lee, Ji-Yoon Lee, Kyeong Lee, Cho-Rock Jung, Min Ju Kim, Jung Ah Kim, Dong Gu Yoo, Eun Jin Shin & Soo Jin Oh. (2021) Metabolite Profiling and Characterization of LW6, a Novel HIF-1α Inhibitor, as an Antitumor Drug Candidate in Mice. Molecules 26:7, pages 1951.
Crossref
Andrea Idili, Julian Gerson, Tod Kippin & Kevin W. Plaxco. (2021) Seconds-Resolved, In Situ Measurements of Plasma Phenylalanine Disposition Kinetics in Living Rats. Analytical Chemistry 93:8, pages 4023-4032.
Crossref
Ruba S. Darweesh, Tamam El-Elimat, Aref Zayed, Tareq N. Khamis, Wahby M. Babaresh, Tawfiq Arafat & Ahmed H. Al Sharie. (2020) The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats. BMC Pharmacology and Toxicology 21:1.
Crossref
Ruba S. Darweesh, Tareq N. Khamis & Tamam El-Elimat. (2020) The effect of cannabidiol on the pharmacokinetics of carbamazepine in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 393:10, pages 1871-1886.
Crossref
Nina Isoherranen & Robert S. Foti. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters 273 309 .
William R. Wolowich, Robert Greif, Maren Kleine-Brueggeney, Werner Bernhard & Lorenz Theiler. (2019) Minimal Physiologically Based Pharmacokinetic Model of Intravenously and Orally Administered Delta-9-Tetrahydrocannabinol in Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics 44:5, pages 691-711.
Crossref
Jian Zhou & Yong Ma. (2018) The importance of metabolite pharmacokinetics studies in drug development. International Journal of Pharmacokinetics 3:1, pages 5-9.
Crossref
Hoa Q. Nguyen, Jian Lin, Emi Kimoto, Ernesto Callegari, Susanna Tse & R. Scott Obach. (2017) Prediction of Losartan-Active Carboxylic Acid Metabolite Exposure Following Losartan Administration Using Static and Physiologically Based Pharmacokinetic Models. Journal of Pharmaceutical Sciences 106:9, pages 2758-2770.
Crossref
Ken Grime, Rikard Pehrson, Pär Nordell, Michael Gillen, Wolfgang Kühn, Timothy Mant, Marie Brännström, Petter Svanberg, Barry Jones & Clive Brealey. (2016) An S‐warfarin and AZD1981 interaction: in vitro and clinical pilot data suggest the N‐deacetylated amino acid metabolite as the primary perpetrator . British Journal of Clinical Pharmacology 83:2, pages 381-392.
Crossref
Tsubasa Hasegawa, Satomi Nakanishi, Keiko Minami, Haruki Higashino, Makoto Kataoka, Yoshihisa Shitara & Shinji Yamashita. (2017) Increase in the systemic exposure of primary metabolites of Midazolam in rat arising from CYP inhibition or hepatic dysfunction. Drug Metabolism and Pharmacokinetics 32:1, pages 69-76.
Crossref
Qi Joy Yang & K. Sandy Pang. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 83 101 .
IE Templeton, Y Chen, J Mao, J Lin, H Yu, S Peters, M Shebley & MV Varma. (2016) Quantitative Prediction of Drug–Drug Interactions Involving Inhibitory Metabolites in Drug Development: How Can Physiologically Based Pharmacokinetic Modeling Help?. CPT: Pharmacometrics & Systems Pharmacology 5:10, pages 505-515.
Crossref
I. J. Martin, S. E. Hill, J. A. Baker, S. V. Deshmukh & E. F. Mulrooney. (2016) A Pharmacokinetic Modeling Approach to Predict the Contribution of Active Metabolites to Human Efficacious Dose. Drug Metabolism and Disposition 44:8, pages 1435-1440.
Crossref
A. R. Masters, B. T. Gufford, J. B. L. Lu, I. F. Metzger, D. R. Jones & Z. Desta. (2016) Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers. Journal of Pharmacology and Experimental Therapeutics 358:2, pages 230-238.
Crossref
Adriana Maria Calvo, Gabriel Mulinari Santos, Thiago Jos? Dion?sio, Maria Paula Marques, Daniel Thomas Brozoski, Vera L?cia Lanchote, Maria Helena Raposo Fernandes, Fl?vio Augusto Cardoso Faria & Carlos Ferreira Santos. (2016) Quantification of piroxicam and 5?-hydroxypiroxicam in human plasma and saliva using liquid chromatography?tandem mass spectrometry following oral administration. Journal of Pharmaceutical and Biomedical Analysis 120, pages 212-220.
Crossref
Tjerk Bueters, Christopher Gibson & Sandra A G Visser. (2015) Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery. Future Medicinal Chemistry 7:17, pages 2351-2369.
Crossref
Ji-Yoon Lee, Sang Yoon Lee, KiHo Lee, Soo Jin Oh & Sang Kyum Kim. (2015) Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM–IDA–EPI method. Chemico-Biological Interactions 229, pages 109-118.
Crossref
Bill J. Smith, Yazdi Pithavala, Hai-Zhi Bu, Ping Kang, Brian Hee, Alan J. Deese, William F. Pool, Karen J. Klamerus, Ellen Y. Wu & Deepak K. Dalvie. (2014) Pharmacokinetics, Metabolism, and Excretion of [ 14 C]Axitinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Humans . Drug Metabolism and Disposition 42:5, pages 918-931.
Crossref
Cho-Ming Loi, Dennis A. Smith & Deepak Dalvie. (2013) Which Metabolites Circulate?. Drug Metabolism and Disposition 41:5, pages 933-951.
Crossref
R. Scott Obach. (2013) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and Pharmacotherapy. Pharmacological Reviews 65:2, pages 578-640.
Crossref
Ans Punt, Walter Brand, Albertinka J. Murk, Annemarie P. van Wezel, Merijn Schriks & Minne B. Heringa. (2013) Effect of combining in vitro estrogenicity data with kinetic characteristics of estrogenic compounds on the in vivo predictive value. Toxicology in Vitro 27:1, pages 44-51.
Crossref
Justin D. Lutz & Nina Isoherranen. (2012) Prediction of Relative In Vivo Metabolite Exposure from In Vitro Data Using Two Model Drugs: Dextromethorphan and Omeprazole. Drug Metabolism and Disposition 40:1, pages 159-168.
Crossref
Caleb M. Woods, Cristina Fernandez, Kent L. Kunze & William M. Atkins. (2011) Allosteric Activation of Cytochrome P450 3A4 by α-Naphthoflavone: Branch Point Regulation Revealed by Isotope Dilution Analysis. Biochemistry 50:46, pages 10041-10051.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.